Using AI to deliver smarter HIV treatment

Researchers from Western University recently made a splash with news that a HIV vaccine (SAV001) has made its way through initial clinical trials, and will be now tested on humans.

“We were very excited with the Phase I results,” the researchers say. “The trial demonstrated that our vaccine stimulates broadly neutralizing antibodies that will neutralize not only single sub-types of HIV, but other sub-types, which means that you can have the vaccine cover many different strains of the virus.”

Despite this apparent progress however, there is still clearly much to be done to tackle a disease that affects some 17 million people around the world.  This number remains high despite the number of people being infected by the HIV virus actually going down, with this apparent dichotomy largely because a cocktail of treatments is able to keep patients alive for longer.

Read the full story by

Tags:

RELATED READS
Mobile health apps improve but do they help the neediest patients? Making wearable data fit for research

From our Network

Tips For Selecting The Right LMS For Your Organization

Transforming Learning: Using Video For Cognitive, Emotional, And Social Engagement

LITE 2017

Improve Your Learning Design Skills With Elucidat's Expert-Created Masterclass Topics

How Can You Easily Find The eLearning Courses Your Team Needs?